News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
More breast cancer patients should be offered BRCA gene testing, new research shows
Many more people with breast cancer could get tested for mutations in the BRCA1 and BRCA2 genes under new criteria, a study suggests.
ICR responds to Government report produced following Accelerated Access Review
The Institute of Cancer Research, London, today responds to the Government’s announcement of a new, fast-track route into the NHS for 'breakthrough' medicines and technologies. This announcement is a response to 2016's Accelerated Access Review.
New blood test detects early resistance to BRCA-targeting drugs for breast and ovarian cancer
Scientists have developed a new highly sensitive blood test to deliver precision medicine to women with BRCA mutations who have breast or ovarian cancer.
Special device facilitates imaging of mice on clinical MRI scanners for neuroblastoma research
A special device for holding mice while they undergo magnetic resonance imaging (MRI) scans on clinical MRI machines – those used on humans – can enhance imaging investigations in mouse models of neuroblastoma, researchers have found.
-547x410.jpg?sfvrsn=2c1d545c_2 "A high magnification image of ovarian clear cell carcinoma (photo: Nephron) 547x410")
How we’re commercialising a pioneering cancer drug
In advance of industry conference BIO-Europe, Henry French speaks to the Enterprise Unit’s Dr Toby Richardson about one of the most promising commercialisation opportunities in our partnering portfolio.
The ICR named UK’s top higher education institution for commercial earnings
The Institute of Cancer Research, London, is now the most successful higher education institution in the UK at earning invention income from its research.
New targeted cancer drug shows signs of effectiveness in first clinical trial
A new targeted cancer drug has a good safety profile and has led to responses in some patients with particular genetic characteristics in their tumours.
Pioneering imaging tech measures cell changes in melanoma
A cutting-edge form of non-invasive imaging technology can track the response of malignant melanoma cells to treatment, researchers have found.
Government minister Lord Prior visits The London Cancer Hub
Transport links in Sutton, and the potential for science to drive economic growth, were two of the themes of a visit by Government minister Lord Prior to The London Cancer Hub.
Cancer relapse linked to body’s own immune system
Cancer cells that survive after treatment may use the body’s own immune system to wake themselves up and fuel their growth, a new study shows.
Breakthrough for advanced head and neck cancer patients as nivolumab made available on the Cancer Drugs Fund
The immunotherapy nivolumab has today been made available on the Cancer Drugs Fund (CDF) for patients with head and neck cancer if the disease progresses within six months of receiving platinum chemotherapy.
New myeloma clinical trial launches with aim to transform treatment from one-size-fits-all approach
People with newly diagnosed high risk myeloma will be treated based on the results of genetic testing as part of a new UK-first clinical trial.
